|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290.30 DKK | -1.76% |
|
+4.42% | -10.75% |
| 05-08 | Novo Nordisk sales surge in India following price cuts | FW |
| 05-08 | Lilly's obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake | RE |
| Capitalization | 1,287B 203B 172B 158B 149B 278B 19,146B 280B 1,870B 729B 9,197B 761B 745B 31,751B | P/E ratio 2026 * |
13.2x | P/E ratio 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise value | 1,403B 221B 188B 172B 162B 303B 20,872B 305B 2,038B 795B 10,026B 829B 812B 34,613B | EV / Sales 2026 * |
4.82x | EV / Sales 2027 * | 4.69x |
| Free-Float |
71.44% | Yield 2026 * |
3.84% | Yield 2027 * | 3.75% |
Last Transcript: Novo Nordisk A/S
Trading Novo Nordisk A/S
| 1 day | -1.76% | ||
| 1 week | +4.42% | ||
| Current month | +6.63% | ||
| 1 month | +20.91% | ||
| 3 months | -1.76% | ||
| 6 months | -0.31% | ||
| Current year | -10.75% |
| 1 week | 278.05 |  | 312.05 |
| 1 month | 235.95 | | 312.05 |
| Current year | 224.25 | | 409.95 |
| 1 year | 224.25 | | 533.4 |
| 3 years | 224.25 | | 1,033.2 |
| 5 years | 224.25 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 06/08/2025 | |
| Director of Finance/CFO | 55 | 14/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 06/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 22/03/2017 |
| Director/Board Member | 51 | 21/03/2018 | |
| Director/Board Member | 61 | 23/03/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.34% | 5.4% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.76% | +4.42% | -32.32% | -49.34% | 203B | |
| -2.72% | -1.54% | +26.22% | +119.18% | 846B | |
| -0.53% | -2.58% | +42.18% | +36.36% | 533B | |
| -0.57% | -2.44% | +8.61% | +36.69% | 356B | |
| -0.94% | -0.97% | +21.32% | +10.98% | 324B | |
| +0.23% | -1.24% | +31.68% | +11.93% | 282B | |
| +0.05% | -2.19% | +24.42% | +20.97% | 278B | |
| -0.82% | -0.70% | +43.44% | -5.91% | 275B | |
| +0.79% | +0.57% | +21.93% | +41.38% | 179B | |
| -2.04% | -0.24% | +33.79% | +67.11% | 163B | |
| Average | -0.61% | -0.69% | +22.13% | +28.93% | 343.89B | |
| Weighted average by Cap. | -0.84% | -1.22% | +24.77% | +44.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 291B 45.85B 38.96B 35.65B 33.65B 62.77B 4,331B 63.32B 423B 165B 2,080B 172B 168B 7,182B | 298B 46.97B 39.91B 36.52B 34.47B 64.3B 4,436B 64.87B 433B 169B 2,131B 176B 173B 7,356B |
| Net income | 97.23B 15.32B 13.01B 11.91B 11.24B 20.97B 1,447B 21.15B 141B 55.07B 695B 57.47B 56.26B 2,399B | 95.11B 14.98B 12.73B 11.65B 11B 20.51B 1,415B 20.69B 138B 53.87B 680B 56.22B 55.03B 2,347B |
| Net Debt | 116B 18.28B 15.53B 14.21B 13.41B 25.02B 1,726B 25.24B 169B 65.71B 829B 68.57B 67.12B 2,862B | 113B 17.77B 15.1B 13.82B 13.04B 24.33B 1,678B 24.54B 164B 63.9B 806B 66.67B 65.27B 2,783B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/26 | 290.30 kr | -1.76% | 4,614,317 |
| 07/05/26 | 295.50 kr | +0.85% | 5,530,016 |
| 06/05/26 | 293.00 kr | +2.48% | 15,205,850 |
| 05/05/26 | 285.90 kr | +1.04% | 6,780,981 |
| 04/05/26 | 282.95 kr | +1.78% | 7,697,853 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition